Bevacizumab and Retinal Vascular Occlusions

Phase 3

Withdrawn

• Conditions: Edema Macular; Vascular Occlusion

• Registration Number: NCT00347711
• Lead Sponsor: Asociación para Evitar la Ceguera en México

Brief Summary

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06
• Primary Completion: 2006-06
• Study Completion: 2006-06
• Study First Submitted: 2006-06-30
• Study First Submitted QC: 2006-07-03
• Study First Posted: 2006-07-04
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-31
• Last Update Posted: 2024-06-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria

• Previous surgery
• Uveitis
• Glaucoma

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Asociacion para Evitar la Ceguera en Mexico; 🇲🇽 Mexico, D.F. Mexico, Mexico